Harvard Psychopharmacology: A Master Class 2026

Advanced Clinical Psychopharmacology, Novel Therapeutics & Complex Psychiatric Care

Course Date: March 20–21, 2026
Format: HD Video Lectures + PDF Materials + VTT Subtitles
Videos: 19
Subtitle Files: 19 VTT
PDFs: 17
Total Size: 6.76 GB
Language: English
Target Audience: Psychiatrists, Nurse Practitioners & Primary Care Physicians

Course Overview

Harvard Psychopharmacology: A Master Class 2026 is an advanced educational program designed for prescribing clinicians who want to strengthen their understanding of contemporary psychiatric pharmacotherapy and emerging treatment strategies.

Through 19 expert-led video sessions, the course connects advances in neuroscience with practical clinical decision-making. Faculty explore the neurobiology underlying psychiatric disorders, evidence-based medication strategies, novel therapeutics, and approaches to some of the most challenging situations encountered in psychiatric practice.

The program places particular emphasis on difficult-to-treat depression, bipolar disorder, schizophrenia, anxiety disorders, substance use disorders, sleep disturbances, and psychopharmacology across specialized patient populations.

Participants will also explore rapidly evolving areas of psychiatric treatment, including neuromodulation, psychedelic mechanisms and their potential role in PTSD, digital therapeutics, Apps and AI, and laboratory approaches to predicting antidepressant response.

What You’ll Learn

By completing this program, participants will be better prepared to:

• Connect neurobiology with clinical practice by understanding brain function and its relevance to psychiatric treatment decisions.
• Evaluate advanced treatment strategies for refractory and difficult-to-treat depression.
• Optimize management of bipolar disorders, including rational polypharmacy and bipolar depression.
• Apply psychopharmacologic principles to perinatal mood and anxiety disorders.
• Review medication approaches for children and adolescents with affective disorders.
• Understand current and emerging neuromodulation approaches relevant to prescribing clinicians.
• Adapt psychiatric treatment for geriatric and neuropsychiatric populations.
• Review contemporary strategies across the spectrum of schizophrenia, from prodromal illness and first episode to relapse and emerging treatments.
• Explore the relationship between sleep neurobiology and psychiatric disorders.
• Examine the emerging roles of Apps and artificial intelligence as therapeutics.
• Understand current research into psychedelic mechanisms and their potential application in PTSD.
• Strengthen evidence-based approaches to substance use disorders and anxiety-spectrum disorders.
• Evaluate the possibilities and limitations of laboratory testing for predicting antidepressant response.

Complete Course Topics

1. Neurobiology for the Practicing Clinician

Update on brain function and its clinical relevance to psychiatric practice.

2. Antidepressant Development for Refractory Depression

Current advances and emerging strategies for patients who do not respond adequately to conventional antidepressant treatment.

3. Treatment of Bipolar Disorders

Rational polypharmacy, bipolar depression, and contemporary approaches to complex management.

4. Psychopharmacology in Perinatal Mood & Anxiety Disorders

Clinical considerations surrounding pharmacologic treatment during the perinatal period.

5. Childhood & Adolescent Affective Disorders

Psychopharmacologic approaches for younger patient populations.

6. Panel Discussion 1

Expert discussion integrating key clinical issues from the preceding sessions.

7. Current & Emerging Neuromodulation Approaches

An update for prescribers on evolving neuromodulation strategies in psychiatric treatment.

8. Psychopharmacology in Geriatrics & Neuropsychiatry

Treatment considerations for older adults and neuropsychiatric populations.

9. Difficult-to-Treat Depression

Therapeutic approaches to complex patients and persistent depressive illness.

10. Panel Discussion 2

Faculty perspectives and discussion of challenging clinical scenarios.

11. Current Treatment for Schizophrenia

Prodrome, first episode, relapse, and emerging treatment possibilities.

12. Sleep in Psychiatric Disorders

Neurobiology and treatment of sleep disturbances within psychiatric illness.

13. Apps & AI as Therapeutics

Exploring digital tools and artificial intelligence in the evolving psychiatric treatment landscape.

14. Psychedelics & PTSD

Mechanisms of psychedelics and their potential therapeutic role in post-traumatic stress disorder.

15. Panel Discussion 3

Expert discussion of emerging and innovative psychiatric treatments.

16. Effective Treatment of Substance Use Disorders

Current therapeutic strategies for managing substance-related disorders.

17. Anxiety Spectrum Disorders

Anxiety mechanisms, treatment strategies, and new data surrounding benzodiazepines.

18. Laboratory Testing & Antidepressant Response

The current status, problems, and promises of laboratory testing designed to predict treatment response.

19. Panel Discussion 4

Final expert discussion integrating major concepts and clinical applications from the master class.

Who Should Take This Course?

This advanced program is particularly relevant for:

Psychiatrists seeking current evidence and advanced strategies for complex psychiatric pharmacotherapy.

Nurse Practitioners involved in psychiatric assessment, medication management, and longitudinal mental health care.

Primary Care Physicians who routinely encounter depression, anxiety, sleep disorders, substance use disorders, and other psychiatric conditions in clinical practice.

The course may also be useful to other prescribing clinicians seeking a structured update on modern psychopharmacology and emerging psychiatric therapeutics.

Course Package

Your course materials include:

19 HD Video Lectures
Complete educational sessions covering advanced psychopharmacology and emerging therapeutics.

19 VTT Subtitle Files
English subtitle files accompanying the video material for easier review and study.

17 PDF Documents
Supporting educational materials for reference and reinforcement of key concepts.

6.76 GB Total Content
A comprehensive digital collection designed for convenient self-paced study.

Why This Master Class Is Valuable

Psychopharmacology continues to evolve rapidly. Clinicians must navigate not only established medications but also new biological models, treatment-resistant illness, emerging technologies, neuromodulation, novel therapeutics, and increasingly individualized approaches to psychiatric care.

Harvard Psychopharmacology: A Master Class 2026 brings these developments together in one advanced program, helping prescribing clinicians translate contemporary psychiatric science into more informed clinical decision-making.